AMB - FUBINACA FUB - AMB MMB - FUBINACA Research Chemical Intermediates CAS No1715016-76-4

 

CAS:	1715016-76-4
Formula:	C21H22FN3O3
Molecular weight:	383.16
Compound purity:	> 99.7%
Appearance:	Powder
IUPAC:	methyl (2S)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3-methylbutanoate

 

AMB-FUBINACA (also known as FUB-AMB and MMB-FUBINACA) is an indazole-based synthetic cannabinoid that is a potent agonist of the CB1 receptor and has been sold online as a designer drug. 

 

It was originally developed by Pfizer which described the compound in a patent in 2009, but was later abandoned and never tested on humans.

 

Identifiers
IUPAC name:
methyl (2S)-2-{[1-[(4-fluorophenyl)methyl]indazole-3-carbonyl]amino}-3-methylbutanoate

 

CAS Number: 
1715016-76-4

 

PubChem CID: 
119026173

 

ChemSpider:
32741679

 

UNII:
TY9AKI870R

 

Chemical and physical data
Formula: C21H22FN3O3
Molar mass: 383.42 g/mol

 

 

Dongmao Biotechnology Co., Limited specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on.

Our products are produced on the basis of best technical team, advanced equipment, high qualified management which meet the requirements of security and environmental protection. We earned customer trust and created a good reputation during these years. we are committed to provide the excellent quality of products and the perfect services to the friends all over the world.

We will provide the most comprehensive products and service to you! We are looking forward to your cooperation.